Faberidilactone A effectively suppressed HepG2 cell migration in vitro and downregulated phosphorylated FAK and MMP-2 expression, indicating its role in inhibiting the FAK pathway and, consequently, tumor metastasis [24,30,31,32]. This evidence concerns the gene MMP2 and neoplasm.